Mitsuhiro Fukata

Scopus著者プロファイル

ウェブサイトhttps://hyoka.ofc.kyushu-u.ac.jp/html/100023087_ja.html

h-index

年別の研究成果

フィンガープリント

Mitsuhiro Fukataが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。

1 類似のプロファイル

43 学術誌
5 総説
2 コメント/討論
1 編集
その他
- 1 レター

Noninvasive machine-learning models for the detection of lesion-specific ischemia in patients with stable angina with intermediate stenosis severity on coronary CT angiography
Hamasaki, H., Arimura, H., Yamasaki, Y., Yamamoto, T., Fukata, M., Matoba, T., Kato, T. & Ishigami, K., 2025, (印刷中) In: Physical and Engineering Sciences in Medicine.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読
Treatment of malignant primary cardiac tumors requires attention to cardiovascular complications: a single-center, retrospective study
Furukawa, K., Ohmura, H., Moriyama, S., Uehara, K., Ito, M., Tsuchihashi, K., Isobe, T., Ariyama, H., Fukata, M., Kusaba, H., Shiose, A., Akashi, K. & Baba, E., 2月 1 2025, In: Japanese journal of clinical oncology. 55, 2, p. 113-122 10 p.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読
Both New-Onset and Pre-Existing Hypertension Indicate Favorable Clinical Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor Therapy
Moriyama, S., Hieda, M., Kisanuki, M., Kawano, S., Yokoyama, T., Fukata, M., Kusaba, H., Maruyama, T., Baba, E., Akashi, K. & Fukuda, H., 2024, In: Circulation Journal. 88, 2, p. 217-225 9 p.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

Open Access
2 被引用数 (Scopus)
Inorganic sulfides prevent osimertinib-induced mitochondrial dysfunction in human iPS cell-derived cardiomyocytes
Kondo, M., Nakamura, Y., Kato, Y., Nishimura, A., Fukata, M., Moriyama, S., Ito, T., Umezawa, K., Urano, Y., Akaike, T., Akashi, K., Kanda, Y. & Nishida, M., 10月 2024, In: Journal of Pharmacological Sciences. 156, 2, p. 69-76 8 p.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

Open Access
2 被引用数 (Scopus)
Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug–induced thromboembolism
Hatakeyama, K., Kikushige, Y., Ishihara, D., Yamamoto, S., Kawano, G., Tochigi, T., Miyamoto, T., Sakoda, T., Christoforou, A., Kunisaki, Y., Fukata, M., Kato, K., Ito, T., Handa, H. & Akashi, K., 2月 13 2024, In: Blood Advances. 8, 3, p. 785-796 12 p.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

Open Access
1 被引用数 (Scopus)

深田光敬

フィンガープリント

過去5年の共同研究と上位研究分野

詳細を開く

Noninvasive machine-learning models for the detection of lesion-specific ischemia in patients with stable angina with intermediate stenosis severity on coronary CT angiography

Treatment of malignant primary cardiac tumors requires attention to cardiovascular complications: a single-center, retrospective study

Both New-Onset and Pre-Existing Hypertension Indicate Favorable Clinical Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor Therapy

Inorganic sulfides prevent osimertinib-induced mitochondrial dysfunction in human iPS cell-derived cardiomyocytes

Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug–induced thromboembolism

深田 光敬

フィンガープリント

過去5年の共同研究と上位研究分野

研究成果

Noninvasive machine-learning models for the detection of lesion-specific ischemia in patients with stable angina with intermediate stenosis severity on coronary CT angiography

Treatment of malignant primary cardiac tumors requires attention to cardiovascular complications: a single-center, retrospective study

Both New-Onset and Pre-Existing Hypertension Indicate Favorable Clinical Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor Therapy

Inorganic sulfides prevent osimertinib-induced mitochondrial dysfunction in human iPS cell-derived cardiomyocytes

Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug–induced thromboembolism

深田光敬